Agilent Tape Station Service Contract
Closed Solicitation Posted
- Solicitation number
- 2026-Q-97416
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention seeks an annual service agreement for Agilent TapeStation instrument maintenance and repair, with responses due July 28, 2026. This is a sole-source procurement awarded to Agilent Technologies, Inc., the original equipment manufacturer; no competitive solicitation will be issued.
Place of performance is Atlanta, Georgia (1600 Clifton Road, Atlanta, Georgia 30329). The Agilent TapeStation 4150 instruments automate quality control for RNA, DNA, and protein samples in HIV prevention research. Only Agilent possesses the proprietary diagnostic software, authorized technical data, internal schematics, and OEM-certified replacement parts required to service, troubleshoot, and maintain the equipment. Using non-OEM technicians would compromise system integrity and void manufacturer warranties. The authority for sole source is FAR Part 5.201 and FAR Part 12.102(a), justified under FAR 13.106-1(b)(1) by exclusive licensing and proprietary data rights.
The estimated cost is $8,953.52 per year. The period of performance is base year September 1, 2026 through August 31, 2027, plus two optional one-year renewal periods through August 31, 2029, totaling $26,860.56 over all periods. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing; the PSC code is J066, Maint/Repair/Rebuild Of Equipment—Instruments And Laboratory Equipment. The contract is available on GSA Schedule GS-07F-0564X.
Service requirements include at least one annual on-site preventive maintenance visit per OEM specifications, unlimited emergency repairs (including travel and parts) with 24-hour response and 72-business-hour service scheduling, genuine OEM parts only, detailed service reports within 5 business days, and compliance with CDC site rules with CDC employee accompaniment at all times. Payment is made yearly or quarterly in arrears. Any interested vendor must submit written verifiable proof of OEM authorization to service this equipment model and immediate access to genuine OEM parts.
Notice text
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch intends to award a firm-fixed price, sole source purchase order to Agilent Technologies, Inc., 2850 Centerville Rd, Wilmington, Delware 19808-1610 for the purchase of an annual service agreement.
The authority for this sole source acquisition is in accordance with FAR Part 5.201 and FAR Part 12.102(a).
The Agilent TapeStation Instrument currently utilized by National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch contains highly specialized and proprietary technical capabilities developed exclusively by Agilent Technologies, the Original Equipment Manufacturer (OEM). Agilent Technologies retains exclusive rights to the technical data, internal schematics, and specialized diagnostic software required to properly service, troubleshoot, and maintain this equipment. No third-party vendors possess the authorized diagnostic tools, proprietary software patches, or OEM-certified replacement parts necessary to perform this work. Furthermore, utilizing a non-OEM certified technician would compromise the integrity of the system and void existing manufacturer warranties. Therefore, Agilent Technologies is the only source reasonably available to satisfy the government's requirement without causing severe operational delays or technical risk."
This notice is not a request for competitive quotes, and a formal solicitation will not be issued publicly. However, any responsible source that believes it can fulfill this requirement may submit a comprehensive capability statement. Responses must include written verifiable proof of explicit authorization from the OEM to service this specific equipment model line, access to proprietary OEM diagnostics, and immediate access to genuine OEM parts. Generic capability statements that do not explicitly address these proprietary technical constraints will not be considered."
Capability statements must be submitted via email to the Contracting Specialist, Debra Baker, at xvv9@cdc.gov no later than 3:00 PM EDT on July 28, 2026. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Inquiries shall be sent to Debra Baker by email at xvv9@cdc.gov and reference solicitation #2026-Q-97416 on the subject line.
Files
| File | Type | Posted |
|---|---|---|
| SOW.pdf | ||
| SSJ_FE.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity